Sonendo, Inc. (SONX)
USD 2.19
(6.31%)
USD 2.19
(6.31%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -57.74 Million USD | 0.79% |
| 2022 | -58.2 Million USD | -31.84% |
| 2021 | -44.14 Million USD | -2.02% |
| 2020 | -43.27 Million USD | 4.81% |
| 2019 | -45.45 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -10.24 Million USD | -3.71% |
| 2024 Q2 | -6.67 Million USD | 34.9% |
| 2023 Q1 | -14.81 Million USD | -0.35% |
| 2023 FY | -57.74 Million USD | 0.79% |
| 2023 Q4 | -9.88 Million USD | 38.61% |
| 2023 Q2 | -16.95 Million USD | -14.43% |
| 2023 Q3 | -16.09 Million USD | 5.04% |
| 2022 Q4 | -14.76 Million USD | -1.14% |
| 2022 Q3 | -14.59 Million USD | -2.16% |
| 2022 Q2 | -14.28 Million USD | 1.85% |
| 2022 Q1 | -14.55 Million USD | -7.28% |
| 2022 FY | -58.2 Million USD | -31.84% |
| 2021 Q1 | -9.84 Million USD | 13.91% |
| 2021 FY | -44.14 Million USD | -2.02% |
| 2021 Q4 | -13.56 Million USD | -22.26% |
| 2021 Q3 | -11.09 Million USD | -12.12% |
| 2021 Q2 | -9.89 Million USD | -0.57% |
| 2020 Q2 | -11.16 Million USD | 0.0% |
| 2020 Q1 | -11.16 Million USD | 0.0% |
| 2020 FY | -43.27 Million USD | 4.81% |
| 2020 Q4 | -11.43 Million USD | -19.69% |
| 2020 Q3 | -9.55 Million USD | 14.43% |
| 2019 FY | -45.45 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott Laboratories | 6.47 Billion USD | 100.891% |
| Allurion Technologies Inc. | -78.07 Million USD | 26.044% |
| Artivion, Inc. | 5.74 Million USD | 1105.625% |
| Avanos Medical, Inc. | 4.2 Million USD | 1474.833% |
| Butterfly Network, Inc. | -145.61 Million USD | 60.344% |
| Butterfly Network, Inc. | -145.61 Million USD | 60.344% |
| Bio-Rad Laboratories, Inc. | 383.79 Million USD | 115.045% |
| Boston Scientific Corporation | 2.34 Billion USD | 102.464% |
| Perspective Therapeutics, Inc. | -15.18 Million USD | -280.339% |
| CONMED Corporation | 130.78 Million USD | 144.151% |
| Edwards Lifesciences Corporation | 1.53 Billion USD | 103.764% |
| Paragon 28, Inc. | -37.3 Million USD | -54.77% |
| Glaukos Corporation | -128.7 Million USD | 55.134% |
| Globus Medical, Inc. | 133.14 Million USD | 143.369% |
| Inspire Medical Systems, Inc. | -40.27 Million USD | -43.386% |
| Integer Holdings Corporation | 167.33 Million USD | 134.508% |
| Medtronic plc | 5.14 Billion USD | 101.123% |
| Nevro Corp. | -99.3 Million USD | 41.855% |
| Owlet, Inc. | -28.63 Million USD | -101.673% |
| Penumbra, Inc. | 73.55 Million USD | 178.507% |
| Vicarious Surgical Inc. | -80.66 Million USD | 28.417% |
| Smith & Nephew plc | 425 Million USD | 113.587% |
| STERIS plc | 836.11 Million USD | 106.906% |
| Stryker Corporation | 3.88 Billion USD | 101.485% |
| Vapotherm, Inc. | -39.08 Million USD | -47.756% |
| Zimmer Biomet Holdings, Inc. | 1.27 Billion USD | 104.519% |